We invest in early-stage innovative life science companies of strategic interest.
At Sanofi-Genzyme BioVentures we are different from traditional venture capital firms: we only invest in early-stage life science companies developing innovative products or technologies of interest to Sanofi. In 2017, we expanded our mandate to seed, lead and co-lead investments in order to maximize our impact to Sanofi. We also back our financial support with world class technical and strategic guidance through access to the Sanofi teams.
"The Sanofi-Genzyme BioVentures Fund allows us to build longstanding relationships with today’s innovators that could lead to future product opportunities."
Vice-President and Managing Director